Filing Details
- Accession Number:
- 0001415889-24-012359
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-06 17:26:00
- Reporting Period:
- 2024-05-02
- Accepted Time:
- 2024-05-06 17:26:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597264 | Blueprint Medicines Corp | BPMC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651036 | Michael Landsittel | C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-02 | 10,000 | $36.05 | 57,286 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-02 | 10,000 | $105.00 | 47,286 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-05-02 | 10,000 | $0.00 | 10,000 | $36.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-02-16 | No | 4 | M | Direct |
Footnotes
- Effected through a trading plan adopted on December 6, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This option was granted on February 16, 2017 and is fully vested as of the transaction date.
Billionaire Hedge Funds
